0% found this document useful (0 votes)
40 views17 pages

Session 14-Pharmacotherapy of Gonorrhoea

gonorrhoea

Uploaded by

boazcairo2
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
40 views17 pages

Session 14-Pharmacotherapy of Gonorrhoea

gonorrhoea

Uploaded by

boazcairo2
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 17

PST 06106

Basic Pharmacotherapy
Session 14: Pharmacotherapy of
Gonorrhea
Learning Objective
By the end of this session students are expected to be able to:
• Define gonorrhoea
• Explain pathophysiology of gonorrhoea
• Explain the clinical presentation of gonorrhoea
• Outline diagnosis of gonorrhoea
• Describe pharmacological treatment of gonorrhoea
• Describe monitoring of gonorrhoea therapy
Activity: Buzzing

•What is Gonorrhoea ?
Definition of Gonorrhea
• Gonorrhea is a sexually transmitted disease (STD) caused by infection
with the bacterium Neisseria gonorrhoeae.
• It tends to infect warm, moist areas of the body, including the:
• Urethra (the tube that drains urine from the urinary bladder)
• Eyes
• Throat
• Vagina
• Anus
• Female reproductive tract (the fallopian tubes, cervix, and uterus)
Definition of Gonorrhea
• Gonorrhea is transmitted from person to person
through unprotected oral, anal, or vaginal sex.
• People with numerous sexual partners or those who don’t use a
condom are at greatest risk of infection.
Pathophysiology of Gonorrhea
• On contact with a mucosal surface lined by columnar, cuboidal, or
noncornified squamous epithelial cells, the gonococci attach to cell
membranes by means of surface pili and are then pinocytosed.
• The virulence of the organism is mediated primarily by the presence
of pili and other outer membrane proteins.
• After mucosal damage is established, polymorphonuclear (PMN)
leukocytes invade the tissue, submucosal abscesses form, and
purulent exudates are secreted.
Clinical Presentation of
Gonorrhea
• Individuals infected with gonorrhea can be;
• symptomatic or asymptomatic,
• have complicated or uncomplicated infections, and
• Have infections involving several anatomic sites.
• Complications associated with untreated gonorrhea appear more
pronounced in women, because most of them are asymptomatic
• As a result, most of these patients develop serious complications, such
as;
• pelvic inflammatory disease (PID),
• Infertility and ectopic pregnancies.
• In other patients the gonococci invade the bloodstream and produce
disseminated disease
Diagnosis of Gonorrhea
• Diagnosis of gonococcal infections can be made by ;
• gram-stained smears,
• culture, or
• Methods based on the detection of cellular components of the
gonococcus such as Enzyme immunoassay, DNA probe techniques,
and nucleic acid amplification techniques (NAATs) are also used in
clinical specimens.
• Various stains have been used to identify gonococci microscopically,
with the Gram stain the most widely used in clinical practice.
• Gram-stained smears are positive for gonococci when gram-
negative diplococci of typical kidney bean morphology are
identified within PMN leukocytes.
Activity: Small Group Discussion
• What is the treatment of Gonorrhoea?
Pharmacological treatment of
gonorrhea
• Uncomplicated gonococcal infection
• Recommended Regimen
• Ceftriaxone 250mg IM in a single dose PLUS
• Azithromycin 1g orally in a single dose
• Alternative regimen
• If ceftriaxone is not available.
• Cefixime 400mg orally in a single dose plus
• Azithromycin 1g orally in a single dose
Treatment of various forms of
Gonorrhea Infection
Monitoring Of Gonorrhea Therapy
• It is recommended to obtain follow-up cultures at least 3 days after
treatment
• However the combination gonorrhea and chlamydial therapy
rarely results in treatment failures, and routine follow-up of
patients treated with a regimen is not necessary.
• Persistence of symptoms following any treatment requires culture of
the site(s) of gonorrheal infection, as well as susceptibility testing if
gonococci are isolated.
Monitoring Of Gonorrhea
Therapy Cont..
• In most cases, the presence of gonococci indicates reinfection rather
than treatment failure and reflects the need for improved patient
education and sex partner referral.
• Persistence of symptoms also can be caused by other infectious
causes, such as C. trachomatis
Key Points
• Gonorrhea is a sexually transmitted disease (STD).
• It’s caused by infection with the bacterium Neisseria gonorrhoeae
• Gonorrhea passes from person to person through unprotected oral,
anal, or vaginal sex.
• First line drug treatment with Cetriaxone and Azithromycin is
recommended
Evaluation
• What is Gonorrhoea?
• What is the pathophysiology of Gonorrhoea?
• What are the signs and symptoms of Gonorrhoea?
• How is the treatment of Gonorrhoea?
References
• Wells BG, DiPiro J, Schwinghammer T (2013), Pharmacotherapy
Handbook (6th Ed). New York, NY: McGraw-Hill.
• DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey ML, (2008):
Pharmacotherapy: A Pathophysiologic Approach (7th ed): New York,
NY: McGraw-Hill.
• Katz M D., Matthias KR., Chisholm-Burns M A.,
Pharmacotherapy(2011) Principles & Practice Study Guide: A Case-
Based Care Plan Approach: New York, NY: McGraw-Hill.
• Schwinghammer TL, Koehler JM (2009) Pharmacotherapy Casebook:
A Patient-Focused Approach (7th ed): New York, NY: McGraw-Hill.

You might also like